Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs

The therapeutic landscape of metastatic hormone sensitive and metastatic castration-resistant prostate cancer (mCRPC) is rapidly changing. We reviewed the current treatment options for mCRPC, with insights on new available therapeutic strategies. Chemotherapy with docetaxel or cabazitaxel (for patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferretti, Simone, Mercinelli, Chiara, Marandino, Laura, Litterio, Giulio, Marchioni, Michele, Schips, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312338/
https://www.ncbi.nlm.nih.gov/pubmed/37396015
http://dx.doi.org/10.2147/RRU.S385257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312338/
https://www.ncbi.nlm.nih.gov/pubmed/37396015
http://dx.doi.org/10.2147/RRU.S385257

Ejemplares similares